Institutional investors hold a majority ownership of LLY through the 67.24% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2017, these large investors purchased a net $8.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SJUNDE AP-FONDEN Bought 102.0 Thousand shares of Eli Lilly and Co
STATE STREET GLOBAL ADVISORS LTD... Bought 74.9 Thousand shares of Eli Lilly and Co
CANDRIAM BELGIUM SA Bought 43.6 Thousand shares of Eli Lilly and Co